IL153833A0 - Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches - Google Patents

Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches

Info

Publication number
IL153833A0
IL153833A0 IL15383301A IL15383301A IL153833A0 IL 153833 A0 IL153833 A0 IL 153833A0 IL 15383301 A IL15383301 A IL 15383301A IL 15383301 A IL15383301 A IL 15383301A IL 153833 A0 IL153833 A0 IL 153833A0
Authority
IL
Israel
Prior art keywords
monomeric
chain
regulation
gene expression
switches
Prior art date
Application number
IL15383301A
Other languages
English (en)
Original Assignee
Novartis Ag
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Scripps Research Inst filed Critical Novartis Ag
Publication of IL153833A0 publication Critical patent/IL153833A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15383301A 2000-07-18 2001-07-16 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches IL153833A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61906300A 2000-07-18 2000-07-18
PCT/EP2001/008190 WO2002006463A2 (en) 2000-07-18 2001-07-16 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches

Publications (1)

Publication Number Publication Date
IL153833A0 true IL153833A0 (en) 2003-07-31

Family

ID=24480304

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15383301A IL153833A0 (en) 2000-07-18 2001-07-16 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches

Country Status (10)

Country Link
EP (2) EP1303606B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004504029A (cg-RX-API-DMAC7.html)
AT (1) ATE382691T1 (cg-RX-API-DMAC7.html)
AU (2) AU7254401A (cg-RX-API-DMAC7.html)
CA (1) CA2415726A1 (cg-RX-API-DMAC7.html)
DE (1) DE60132208T2 (cg-RX-API-DMAC7.html)
ES (1) ES2299494T3 (cg-RX-API-DMAC7.html)
IL (1) IL153833A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ523649A (cg-RX-API-DMAC7.html)
WO (1) WO2002006463A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7329728B1 (en) 1999-10-25 2008-02-12 The Scripps Research Institute Ligand activated transcriptional regulator proteins
US7011972B2 (en) 2000-07-18 2006-03-14 The Scripps Research Institute Fusion polypeptide comprising two ligand binding domains
US7070993B2 (en) 2001-03-13 2006-07-04 Novartis Ag Lentiviral packaging constructs
DE60228082D1 (de) 2001-05-31 2008-09-18 Novartis Ag Nten und neue liganden und pharmazeutische zusammensetzungen
US7927840B2 (en) 2006-09-11 2011-04-19 Gen Probe Incorporated Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
CA2501946C (en) 2002-10-16 2014-12-23 Gen-Probe Incorporated Compositions and methods for detecting west nile virus
WO2022049217A1 (en) * 2020-09-04 2022-03-10 Miltenyi Biotec B.V. & Co. KG System for inducible expression of an adapter in immune cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
EP0935657B1 (en) * 1996-10-29 2007-08-29 Baylor College Of Medicine Modified steroid hormone receptors
JP2003524368A (ja) * 1997-08-26 2003-08-19 アリアド ジーン セラピューティクス インコーポレイテッド ニ量化ドメイン、三量化ドメインまたは四量化ドメインおよび補足的非相同転写活性化ドメイン、転写抑制ドメイン、ｄｎａ結合ドメインまたはリガンド結合ドメインを含む融合蛋白
CA2323064C (en) * 1998-03-17 2011-05-31 Gendaq Limited Nucleic acid binding proteins
US6140081A (en) * 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US7057015B1 (en) * 1999-10-20 2006-06-06 The Salk Institute For Biological Studies Hormone receptor functional dimers and methods of their use
US7329728B1 (en) * 1999-10-25 2008-02-12 The Scripps Research Institute Ligand activated transcriptional regulator proteins

Also Published As

Publication number Publication date
DE60132208D1 (de) 2008-02-14
AU7254401A (en) 2002-01-30
ES2299494T3 (es) 2008-06-01
DE60132208T2 (de) 2008-12-24
AU2001272544B2 (en) 2005-12-01
NZ523649A (en) 2005-02-25
EP1908835A2 (en) 2008-04-09
EP1303606A2 (en) 2003-04-23
ATE382691T1 (de) 2008-01-15
WO2002006463A3 (en) 2002-07-25
WO2002006463A2 (en) 2002-01-24
CA2415726A1 (en) 2002-01-24
EP1908835A3 (en) 2008-06-18
EP1303606B1 (en) 2008-01-02
JP2004504029A (ja) 2004-02-12

Similar Documents

Publication Publication Date Title
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
ATE394484T1 (de) Smad 6 und dessen anwendungen
IL142440A0 (en) Zinc finger binding domains for gnn
WO2003012057A3 (en) Antisense modulation of serum amyloid a4 expression
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
WO2003018758A3 (en) Reagents and methods for smooth muscle therapies
WO2001023412A3 (en) Methods of screening for agents which inhibit aggregation of polypeptides
WO2003010284A3 (en) Antisense modulation of c-reactive protein expression
EP0892048A3 (en) XAF genes and polypeptides and their use for modulating apoptosis
DK0960192T3 (da) Syntetiske polynukleotider
WO2002044376A3 (en) Modulation of gene expression using insulator binding proteins
IL153833A0 (en) Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
AU2002228805A1 (en) Antisense modulation of damage-specific dna binding protein 2, p48 expression
WO2002066640A3 (en) Zinc finger binding domains for nucleotide sequence ann
ZA97835B (en) Purified sr-p70 protein
WO2002092765A3 (en) Novel telomerase inhibitors and uses therefor
ZA982009B (en) Isolated nucleic acid molecules encoding SSX family members and uses thereof.
WO1998024896A3 (en) Muteins of obese protein
WO1999028465A3 (en) Pias molecules that recognize and bind stat proteins and uses thereof
NZ512332A (en) Potassium channel interactors and uses therefor
WO2004019283A3 (en) Methods for regulating transcription by targeting quadruplex dna
WO2002070676A3 (en) Use of protein histidine phosphatase
AP9901510A0 (en) Polypeptides comprising gax protein domains, involved in repressing transcription and or interacting with other proteins corresponding nucleic acids andtheir use.
WO2002055659A3 (en) Antisense modulation of integrin beta 4 binding protein expression
FR2758725B1 (fr) Composition comprenant une proteine e2 de papillomavirus ou une sequence de nucleotides codant pour une proteine e2 de papillomavirus